Screener

Eligibility screening

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Sponsored by Neonc Technologies, Inc.Study detailsClinicalTrials.gov

6 US sites in CA, TN, TX, WA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.